Artificial Tears May Not Be Enough

Dry Eye can be a difficult challenge to manage

Artificial tears may provide short-term relief of Dry Eye, but have limitations

  • Patients may have already tried an average of >2 brands1
  • There is no discernible effect beyond lubrication2
  • They may not prevent progression of the disease3

Patients make numerous visits to the eye doctor in an effort to manage Dry Eye1

Indication and Usage: RESTASIS® Ophthalmic Emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

Important Safety Information:

Contraindications: RESTASIS® is contraindicated in patients with active ocular infections and in patients with known or suspected hypersensitivity to any of the ingredients in the formulation.

Warning: RESTASIS® Ophthalmic Emulsion has not been studied in patients with a history of herpes keratitis.

Precautions: RESTASIS® should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to the administration of the emulsion.

Adverse Reactions: The most common adverse event was ocular burning (upon instillation) – 17%. Other events reported in 1% to 5% of patients included conjunctival hyperemia, discharge, epiphora, eye pain, foreign body sensation, pruritus, stinging, and visual disturbance (most often blurring).

Please see full prescribing information for RESTASIS® Ophthalmic Emulsion.

References
  1. Multi-sponsor Surveys, Inc. The 2010 Gallup Study of Dry Eye Sufferers–Summary Volume. Princeton, NJ: Multi-sponsor Surveys, Inc., July 2010.
  2. 2007 Report of the International Dry Eye WorkShop (DEWS). Ocul Surf. 2007;5:67-204.
  3. Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45(suppl 2):S211-S220.